Cargando…
Immune Checkpoint Blockers and Ovarian Cancer
Although the idea, called “cancer immunotherapy,” is very appealing and has previously been shown to work in several mouse models of cancer, it has in general been very difficult to translate cancer immunotherapy approaches to humans. Because of this frustration, by the 1990s, many scientists and bi...
Autor principal: | Bose, Chinmoy K |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5582557/ https://www.ncbi.nlm.nih.gov/pubmed/28900328 http://dx.doi.org/10.4103/ijmpo.ijmpo_73_16 |
Ejemplares similares
-
Immune checkpoints, their control by immunotherapy and ovarian cancer
por: Bose, Chinmoy K.
Publicado: (2017) -
Biomarkers for immune checkpoint blockers
por: Wienand, Kirsty, et al.
Publicado: (2018) -
Immune checkpoint blockade in ovarian cancer
por: Weiss, Lukas, et al.
Publicado: (2016) -
Perspectives of traditional Chinese medicine to patch up immune checkpoint blockers
por: Tsao, Shiu Ying
Publicado: (2022) -
Toward Systems Biomarkers of Response to Immune Checkpoint Blockers
por: Lapuente-Santana, Óscar, et al.
Publicado: (2020)